Account
Publications
15.10.2024
WODC Europe 2024: Are NICE Achieving Their Timelin...

AUTHORS: Amrit Kaliasethi, Tia Kwong, Mariam Bibi OBJECTIVES  In 2013, England’s National Ins...

Read more
Publications
15.10.2024
WODC Europe 2024: Comparing And Contrasting Early ...

AUTHORS: Amy Boyers, Solen Monteil, Mariam Bibi OBJECTIVES  Early Access Programmes (EAPs) prov...

Read more
Publications
22.08.2024
ISPOR Europe 2024 : Proactive Risk Surveillance fo...

This research leverages RWE using a quality-by-design (QbD) framework for proactive risk surveillanc...

Read more
Publications
22.08.2024
ISPOR Europe 2024: Are companies Ready for the New...

We explore whether pharma and biotech manufacturers are ready for the new EU HTA process and what op...

Read more
Publications
22.08.2024
ISPOR Europe 2024: Leveraging Real-World Data for ...

We explore how the integration of real-world data can revolutionise clinical decision support system...

Read more
Publications
22.08.2024
ISPOR Europe 2024: Can Patient Involvement Help Op...

We explore whether including the patient voice in early stages of drug development optimises patient...

Read more
Publications
22.08.2024
ISPOR Europe 2024: Implications of Indication Expa...

We examine the impact of indication expansions on pricing and reimbursement strategies across EU4 an...

Read more
Publications
22.08.2024
ISPOR Europe 2024: Alignment of EU HTA and member ...

We examine whether the joint clinical assessment will expedite patient access and influence value pe...

Read more
Publications
22.08.2024
ISPOR Europe 2024: How Could ATMP’s Demonstr...

This study examines how Advanced Therapy Medicinal Products (ATMPs) demonstrate economic benefit for...

Read more
Publications
22.08.2024
ISPOR Europe 2024: Evaluating the Capabilities of ...

This study investigates the capabilities of AI tools including ChatGPT for conducting pricing and re...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.